PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference
SOUTH PLAINFIELD, N.J., Jan. 3, 2024 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 8, at 7:30 a.m. PST/10:30 a.m. EST.
Related news for (PTCT)
- PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
- PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
- PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)